Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-17-011240)

Filing Details

Accession Number:: 0001127602-17-011240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-10 16:19:09
Reporting Period:: 2017-03-08

Filing Date:: 2017-03-10
Accepted Time:: 2017-03-10 16:19:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882796	Biocryst Pharmaceuticals Inc	BCRX	Biological Products, (No Disgnostic Substances) (2836)	621413174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1230708	Ii R Thomas Staab	4505 Emperor Blvd. Suite 200 Durham NC 27703	Senior Vice President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-03-08	6,500	$3.78	123,813	No	4	M	Direct
Common Stock	Disposition	2017-03-08	3,250	$8.20	120,563	No	4	S	Direct
Common Stock	Disposition	2017-03-08	3,250	$8.65	117,313	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Emp. Stock Option (Right to Buy)	Disposition	2017-03-08	6,500	$0.00	6,500	$3.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
86,260	2012-07-01	2021-07-01	No	4	M	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016.